iRhythm’s Q4 Earnings Beat Expectations, Analysts Remain Bullish On Upcoming Catalysts
iRhythm Technologies Inc (NASDAQ:IRTC) reported Q4 FY22 revenue of $112.6 million, up 37.7% Y/Y beating the consensus of $110.26 million.…
Altair Engineering Likely For Multiple Expansion Backed By Business Resilience, Expanding Margins, Analyst Says
Needham analyst Charles Shi maintained Altair Engineering Inc (NASDAQ:ALTR) with a Buy and raised the price target from $60 to $70. Altair reported…
Why NeoGenomics Shares Are Trading Higher Today
NeoGenomics Inc (NASDAQ:NEO) reported Q4 revenues of $138.71 million, +10.3% Y/Y beating the consensus of $129.97 million but aligned with…
Fiverr Analysts Boost Price Targets Expecting Cohorts And Macro To Stabilize In 2023
Needham analyst Bernie McTernan maintained Fiverr International Ltd (NYSE:FVRR) with a Buy and raised the price target from $40 to $50. The…
Beyond Meat: Investors Anxious To See Q4 Results As Company Struggles To ‘Make Ends Meat’
Alternative meats company Beyond Meat Inc (NASDAQ:BYND) will release fourth-quarter earnings at 5 p.m. EST on Thursday, as…
Raymond James Cuts Camping World Price Target By 7% After Mixed Q4 Earnings
Raymond James analyst Joseph Altobello reiterated an Outperform rating on the shares of Camping World Holdings, Inc.(NYSE:CWH) and lowered the price…
Underlying Expansionary Dynamics At Home Depot Appear Intact, Says Analyst
Oppenheimer analyst Brian Nagel reiterated an Outperform rating on the shares of Home Depot Inc (NYSE:HD) with a price target of $400.…
Economic Uncertainty, Controlled Ad Spend, Lower Visibility Restrict AppLovin’s Upside, Analyst Says
UBS analyst John Hodulik downgraded AppLovin Corp (NASDAQ:APP) from Buy to Neutral and lowered the price target from $59 to $16. While…
Will Nvidia’s Rally Continue After ‘Solid’ Q4 Print? 6 Analysts Take A Closer Look
Shares of Nvidia Corporation (NASDAQ: NVDA) jumped in Thursday’s premarket session, after the company reported quarterly earnings.
Evolent Health Q4 Top-Line Beats Expectation, Analyst Points To Visible Growth Outlook
Evolent Health Inc (NYSE:EVH) reported Q4 adjusted EPS of $0.10, missing the consensus of $0.16, compared to $0.08 a year…